SlideShare a Scribd company logo
Bayer Inc. Merging with
Takeda Pharmaceutical
Maureen, Mine, Alice, Tim & Tope
Over-view of Bayer & Takeda
Bayer has its global office at Leverkusen Germany.
The company comprise of over 302 consolidated companies in over
74 countries globally.
Bayer mission is “Science For A Better Life.”
Its valve is presented by the word LIFE “Leadership, Integrity,
Flexibility and Efficiency.
Takeda was established in June 1781 and incorporated in January
1925, with its headquarters in Japan.
Has over 38,000 employee strength and over 260,784 shareholders
Its business scope comprise R&D, production, distribution,
marketing, export and importation of drugs
Over-view Of Germany
Germany is a democratic country with multi-parties. The
countries system of politics is in the constitution.
Germany is the 3rd largest exporter and importer in the world.
France, Netherlands and China are the top 3 trade partners.
Getting license permits and credit may take a long period of time
and getting loans have stiff procedures and these are major
barriers to trading with Germany.
Over-View Of South Korea
South Korea is officially known as Republic of Korea. Gained
Independence in 1895.
Has a mixed legal system, and the democratic republic consist of
the executive, legislative and judicial branch
Asia’s fourth largest economy with the largest GDP in the world.
The economy is currently moving towards manufacturing and
services.
The country is a member of OECD, and it was ranked the world’s
eighth largest exporter
South Korea has a basic law concerning foreign investment which
is FIPA (Foreign Investment Promotion Act)
The country focuses on FTA (Free Trade Agreement).
Cultural Difference
Germany South Korea
Germans- 91.5%, Turkish 2.4%
and 6.1 % other.
South Korea- Korean English
widely taught in junior high and
high school
Division of labor by gender in
Germany , women are represented
in all walks of life; both sexes
have equal rights
South Korea existence of male
preference, huge gender gap in
education institutions
Homeland of protestant
reformation, mostly protestant
catholic dominated
South Korea , majority opted to
expressing no religious
preference, largely protestant
Christians, Buddhist catholic
and other
Bayer Inc. Mode of Entry To Takeda
Merger
Justification for our entry mode
Once worked with Bayer in 1907
South Korea culture model
Takeda business culture
Takeda most valuable assets.
Bayer Cost Of Investment
The estimated cost of investment will be $36,000,000 as the
company is worth $35,801,600
Breakeven Point
Total fixed expenses
Contribution margin %
Therefore, using the following information as an annual estimation
Total fixed cost 2,000,000
Sales capacity 7,000,000
Variable expenses 750,000
Contribution margin 89%
Breakeven point= 2,000,000/89%
= $2,247,191.
Pay Back Period
year Cash flow ($) Net Invested Cash ($)
0 (36.000,000)
1 10,000,000 (26,000,000)
2 7,000,000 (19,000,000)
3 7,000,000 (12,000,000)
4 7,000,000 (5,000,000)
5 7,000,000
Investment Protection Strategy & Exit
Mode
Dedicate time and resources to obtain valid document of
ownership
Restrict access to files and documents to unauthorized individuals
Create a strategic exit strategy for all agreement and investment
Purchase a comprehensive insurance package that covers all
aspects of business
Implement stop loss on all stock in the event of price fall
Exit through Initial Public Offer (IPO)

More Related Content

Viewers also liked

Q1 2015 Investor Conference Call Presentation Charts
Q1 2015 Investor Conference Call Presentation ChartsQ1 2015 Investor Conference Call Presentation Charts
Q1 2015 Investor Conference Call Presentation ChartsBayer
 
council_improvement_proposal Nambucca Shire
council_improvement_proposal Nambucca Shirecouncil_improvement_proposal Nambucca Shire
council_improvement_proposal Nambucca Shirescott norman
 
Why a CMS needs business adaptation: Case study by Boehringer Ingelheim
Why a CMS needs business adaptation: Case study by Boehringer IngelheimWhy a CMS needs business adaptation: Case study by Boehringer Ingelheim
Why a CMS needs business adaptation: Case study by Boehringer IngelheimDay Software
 
FY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsFY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsBayer
 
Meet management 2014-06-05_ny_investor_handout_web_slideshare
Meet management 2014-06-05_ny_investor_handout_web_slideshareMeet management 2014-06-05_ny_investor_handout_web_slideshare
Meet management 2014-06-05_ny_investor_handout_web_slideshareBayer
 
Syngenta 2014 Full Year Results - Media Presentation
Syngenta 2014 Full Year Results - Media PresentationSyngenta 2014 Full Year Results - Media Presentation
Syngenta 2014 Full Year Results - Media PresentationSyngenta
 
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop Science
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop SciencePistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop Science
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop SciencePistoia Alliance
 
Q2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation ChartsQ2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation ChartsBayer
 
Biocon H1 FY 2012 Results Presentation
Biocon H1 FY 2012 Results PresentationBiocon H1 FY 2012 Results Presentation
Biocon H1 FY 2012 Results PresentationBiocon
 
Bayer...
Bayer...Bayer...
Bayer...EC
 
Bayer Case Study “Scientific Computing”
Bayer Case Study “Scientific Computing”Bayer Case Study “Scientific Computing”
Bayer Case Study “Scientific Computing”AWS Germany
 
A Botanical Introduction to The Biodiversity Heritage Library
A Botanical Introduction to The Biodiversity Heritage LibraryA Botanical Introduction to The Biodiversity Heritage Library
A Botanical Introduction to The Biodiversity Heritage LibraryMartin Kalfatovic
 
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage Library
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage LibraryBotany and the BHL: A Botanical Overview of the Biodiversity Heritage Library
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage LibraryMartin Kalfatovic
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcareinosfera
 
Bayer - NOAH16 Berlin
Bayer - NOAH16 BerlinBayer - NOAH16 Berlin
Bayer - NOAH16 BerlinNOAH Advisors
 
The Future of Pharmacy: Using Technology to Drive Practice Change
The Future of Pharmacy: Using Technology to Drive Practice ChangeThe Future of Pharmacy: Using Technology to Drive Practice Change
The Future of Pharmacy: Using Technology to Drive Practice ChangeJerry Fahrni
 
Bayer CropScience Annual Press Conference 2014
Bayer CropScience Annual Press Conference 2014Bayer CropScience Annual Press Conference 2014
Bayer CropScience Annual Press Conference 2014Bayer Crop Science
 

Viewers also liked (20)

Q1 2015 Investor Conference Call Presentation Charts
Q1 2015 Investor Conference Call Presentation ChartsQ1 2015 Investor Conference Call Presentation Charts
Q1 2015 Investor Conference Call Presentation Charts
 
Pharma trends 2012, AUSTRALIA
Pharma trends 2012, AUSTRALIAPharma trends 2012, AUSTRALIA
Pharma trends 2012, AUSTRALIA
 
council_improvement_proposal Nambucca Shire
council_improvement_proposal Nambucca Shirecouncil_improvement_proposal Nambucca Shire
council_improvement_proposal Nambucca Shire
 
Why a CMS needs business adaptation: Case study by Boehringer Ingelheim
Why a CMS needs business adaptation: Case study by Boehringer IngelheimWhy a CMS needs business adaptation: Case study by Boehringer Ingelheim
Why a CMS needs business adaptation: Case study by Boehringer Ingelheim
 
FY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation ChartsFY/Q4 2014 Investor Conference Call Presentation Charts
FY/Q4 2014 Investor Conference Call Presentation Charts
 
Meet management 2014-06-05_ny_investor_handout_web_slideshare
Meet management 2014-06-05_ny_investor_handout_web_slideshareMeet management 2014-06-05_ny_investor_handout_web_slideshare
Meet management 2014-06-05_ny_investor_handout_web_slideshare
 
Syngenta 2014 Full Year Results - Media Presentation
Syngenta 2014 Full Year Results - Media PresentationSyngenta 2014 Full Year Results - Media Presentation
Syngenta 2014 Full Year Results - Media Presentation
 
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop Science
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop SciencePistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop Science
Pistoia Alliance European Conference 2015 - Jakob de Vlieg / Bayer Crop Science
 
Q2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation ChartsQ2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation Charts
 
Biocon H1 FY 2012 Results Presentation
Biocon H1 FY 2012 Results PresentationBiocon H1 FY 2012 Results Presentation
Biocon H1 FY 2012 Results Presentation
 
Bayer...
Bayer...Bayer...
Bayer...
 
Bayer Case Study “Scientific Computing”
Bayer Case Study “Scientific Computing”Bayer Case Study “Scientific Computing”
Bayer Case Study “Scientific Computing”
 
Lung cancer infographic
Lung cancer infographicLung cancer infographic
Lung cancer infographic
 
A Botanical Introduction to The Biodiversity Heritage Library
A Botanical Introduction to The Biodiversity Heritage LibraryA Botanical Introduction to The Biodiversity Heritage Library
A Botanical Introduction to The Biodiversity Heritage Library
 
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage Library
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage LibraryBotany and the BHL: A Botanical Overview of the Biodiversity Heritage Library
Botany and the BHL: A Botanical Overview of the Biodiversity Heritage Library
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcare
 
Bayer - NOAH16 Berlin
Bayer - NOAH16 BerlinBayer - NOAH16 Berlin
Bayer - NOAH16 Berlin
 
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
 
The Future of Pharmacy: Using Technology to Drive Practice Change
The Future of Pharmacy: Using Technology to Drive Practice ChangeThe Future of Pharmacy: Using Technology to Drive Practice Change
The Future of Pharmacy: Using Technology to Drive Practice Change
 
Bayer CropScience Annual Press Conference 2014
Bayer CropScience Annual Press Conference 2014Bayer CropScience Annual Press Conference 2014
Bayer CropScience Annual Press Conference 2014
 

Similar to Bayer ppt

BEEBrochure-lr
BEEBrochure-lrBEEBrochure-lr
BEEBrochure-lrTjoh
 
ppt on International Trade or Business
ppt on International Trade or Businessppt on International Trade or Business
ppt on International Trade or BusinessVibhor Agarwal
 
International Business Capstone Project Finished
International Business Capstone Project FinishedInternational Business Capstone Project Finished
International Business Capstone Project FinishedJeffrey Thompson
 
dynaCERT Investors Presentation February 2016
dynaCERT Investors Presentation February 2016dynaCERT Investors Presentation February 2016
dynaCERT Investors Presentation February 2016Jim Payne
 
Friedland Global Capital Stock Market Listings
Friedland Global Capital   Stock Market ListingsFriedland Global Capital   Stock Market Listings
Friedland Global Capital Stock Market ListingsRana S
 
Business in Africa Pays: Nigeria Hitachi 2014
Business in Africa Pays: Nigeria Hitachi 2014Business in Africa Pays: Nigeria Hitachi 2014
Business in Africa Pays: Nigeria Hitachi 2014BusinessInAfricaPays.com
 
International business - Manu Melwin Joy
International business - Manu Melwin JoyInternational business - Manu Melwin Joy
International business - Manu Melwin JoyManu Melwin Joy
 
Challenges fesed by haier company
Challenges fesed by haier companyChallenges fesed by haier company
Challenges fesed by haier companyTanzeel Mehmood
 
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014Aranca
 
The Worlds Best Companies 2009
The Worlds Best Companies 2009The Worlds Best Companies 2009
The Worlds Best Companies 2009Sunil Misar
 
WHAT IS INTERNATIONAL BUSINESS?
   WHAT IS INTERNATIONAL BUSINESS?   WHAT IS INTERNATIONAL BUSINESS?
WHAT IS INTERNATIONAL BUSINESS?Best business ideas
 
Global Business Strategy of British Petroleum (BP)
Global Business Strategy of British Petroleum (BP)Global Business Strategy of British Petroleum (BP)
Global Business Strategy of British Petroleum (BP)Faysal Alam
 
Dani's Intimate Apparel Report
Dani's Intimate Apparel ReportDani's Intimate Apparel Report
Dani's Intimate Apparel ReportBrandon T. Luong
 
Power point presentation on tariff and import duties converted
Power point presentation on tariff and import duties convertedPower point presentation on tariff and import duties converted
Power point presentation on tariff and import duties convertedMichell Wiliam
 

Similar to Bayer ppt (20)

BEEBrochure-lr
BEEBrochure-lrBEEBrochure-lr
BEEBrochure-lr
 
Huabao Apr 2012
Huabao Apr 2012Huabao Apr 2012
Huabao Apr 2012
 
ppt on International Trade or Business
ppt on International Trade or Businessppt on International Trade or Business
ppt on International Trade or Business
 
Walid Profile V
Walid Profile VWalid Profile V
Walid Profile V
 
International Business Capstone Project Finished
International Business Capstone Project FinishedInternational Business Capstone Project Finished
International Business Capstone Project Finished
 
dynaCERT Investors Presentation February 2016
dynaCERT Investors Presentation February 2016dynaCERT Investors Presentation February 2016
dynaCERT Investors Presentation February 2016
 
2011.2.05 Marketing
2011.2.05 Marketing2011.2.05 Marketing
2011.2.05 Marketing
 
Friedland Global Capital Stock Market Listings
Friedland Global Capital   Stock Market ListingsFriedland Global Capital   Stock Market Listings
Friedland Global Capital Stock Market Listings
 
Business in Africa Pays: Nigeria Hitachi 2014
Business in Africa Pays: Nigeria Hitachi 2014Business in Africa Pays: Nigeria Hitachi 2014
Business in Africa Pays: Nigeria Hitachi 2014
 
International business - Manu Melwin Joy
International business - Manu Melwin JoyInternational business - Manu Melwin Joy
International business - Manu Melwin Joy
 
Presentation on LG
Presentation on LGPresentation on LG
Presentation on LG
 
Challenges fesed by haier company
Challenges fesed by haier companyChallenges fesed by haier company
Challenges fesed by haier company
 
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014
Aranca Brief | Global Deals (M & A) - Volume-1-1 - September 2014
 
International marketing 5
International marketing 5International marketing 5
International marketing 5
 
The Worlds Best Companies 2009
The Worlds Best Companies 2009The Worlds Best Companies 2009
The Worlds Best Companies 2009
 
WHAT IS INTERNATIONAL BUSINESS?
   WHAT IS INTERNATIONAL BUSINESS?   WHAT IS INTERNATIONAL BUSINESS?
WHAT IS INTERNATIONAL BUSINESS?
 
Global Business Strategy of British Petroleum (BP)
Global Business Strategy of British Petroleum (BP)Global Business Strategy of British Petroleum (BP)
Global Business Strategy of British Petroleum (BP)
 
Session 5 gm
Session 5 gmSession 5 gm
Session 5 gm
 
Dani's Intimate Apparel Report
Dani's Intimate Apparel ReportDani's Intimate Apparel Report
Dani's Intimate Apparel Report
 
Power point presentation on tariff and import duties converted
Power point presentation on tariff and import duties convertedPower point presentation on tariff and import duties converted
Power point presentation on tariff and import duties converted
 

Bayer ppt

  • 1. Bayer Inc. Merging with Takeda Pharmaceutical Maureen, Mine, Alice, Tim & Tope
  • 2. Over-view of Bayer & Takeda Bayer has its global office at Leverkusen Germany. The company comprise of over 302 consolidated companies in over 74 countries globally. Bayer mission is “Science For A Better Life.” Its valve is presented by the word LIFE “Leadership, Integrity, Flexibility and Efficiency. Takeda was established in June 1781 and incorporated in January 1925, with its headquarters in Japan. Has over 38,000 employee strength and over 260,784 shareholders Its business scope comprise R&D, production, distribution, marketing, export and importation of drugs
  • 3. Over-view Of Germany Germany is a democratic country with multi-parties. The countries system of politics is in the constitution. Germany is the 3rd largest exporter and importer in the world. France, Netherlands and China are the top 3 trade partners. Getting license permits and credit may take a long period of time and getting loans have stiff procedures and these are major barriers to trading with Germany.
  • 4. Over-View Of South Korea South Korea is officially known as Republic of Korea. Gained Independence in 1895. Has a mixed legal system, and the democratic republic consist of the executive, legislative and judicial branch Asia’s fourth largest economy with the largest GDP in the world. The economy is currently moving towards manufacturing and services. The country is a member of OECD, and it was ranked the world’s eighth largest exporter South Korea has a basic law concerning foreign investment which is FIPA (Foreign Investment Promotion Act) The country focuses on FTA (Free Trade Agreement).
  • 5. Cultural Difference Germany South Korea Germans- 91.5%, Turkish 2.4% and 6.1 % other. South Korea- Korean English widely taught in junior high and high school Division of labor by gender in Germany , women are represented in all walks of life; both sexes have equal rights South Korea existence of male preference, huge gender gap in education institutions Homeland of protestant reformation, mostly protestant catholic dominated South Korea , majority opted to expressing no religious preference, largely protestant Christians, Buddhist catholic and other
  • 6. Bayer Inc. Mode of Entry To Takeda Merger Justification for our entry mode Once worked with Bayer in 1907 South Korea culture model Takeda business culture Takeda most valuable assets.
  • 7. Bayer Cost Of Investment The estimated cost of investment will be $36,000,000 as the company is worth $35,801,600 Breakeven Point Total fixed expenses Contribution margin % Therefore, using the following information as an annual estimation Total fixed cost 2,000,000 Sales capacity 7,000,000 Variable expenses 750,000 Contribution margin 89% Breakeven point= 2,000,000/89% = $2,247,191.
  • 8. Pay Back Period year Cash flow ($) Net Invested Cash ($) 0 (36.000,000) 1 10,000,000 (26,000,000) 2 7,000,000 (19,000,000) 3 7,000,000 (12,000,000) 4 7,000,000 (5,000,000) 5 7,000,000
  • 9. Investment Protection Strategy & Exit Mode Dedicate time and resources to obtain valid document of ownership Restrict access to files and documents to unauthorized individuals Create a strategic exit strategy for all agreement and investment Purchase a comprehensive insurance package that covers all aspects of business Implement stop loss on all stock in the event of price fall Exit through Initial Public Offer (IPO)